Unique ID issued by UMIN | UMIN000002563 |
---|---|
Receipt number | R000003132 |
Scientific Title | Examination of the utility of the Helicobacter pylori sanitization medical treatment in the chronic hepatitis C and liver cirrhosis |
Date of disclosure of the study information | 2009/10/01 |
Last modified on | 2015/10/17 13:54:37 |
Examination of the utility of the Helicobacter pylori sanitization medical treatment in the chronic hepatitis C and liver cirrhosis
Examination of the utility of the Helicobacter pylori sanitization medical treatment in the chronic hepatitis C and liver cirrhosis
Examination of the utility of the Helicobacter pylori sanitization medical treatment in the chronic hepatitis C and liver cirrhosis
Examination of the utility of the Helicobacter pylori sanitization medical treatment in the chronic hepatitis C and liver cirrhosis
Japan |
chronic hepatitis C and a cirrhosis of the liver patient
Hepato-biliary-pancreatic medicine |
Others
NO
For chronic hepatitis C and a cirrhosis of the liver patient, I examine a change of the sanitization blood platelet value by the type distinction of H.pylori to be able to put after curing and examine necessity of the H.pylori sanitization in the future liver disease patient
Efficacy
Examination according to the H.pylori cause of the disease factor seasonal polymorphism to have an influence on a change of the number of the blood platelets by the H.pylori sanitization medical treatment
I divide blood platelet numerical value before sanitization into the high price group with low value group, and it is examined the number of the blood platelets improvement effect.
The examination of the change of the blood platelet numerical value in the interferon dosage patient.
Portal vein pressure sthenia symptom stomach symptom (PHG),an improvement effect of the gullet varication by the H.pylori sanitization medical treatment.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
I inspect Helicobacter pylori by a serum antibody method.
It is omeprazole 20mg, amoxicillin 750mg, clarithromycin 400mg per day twice oral administration, one week for a Helicobacter pylori positive patient.
I do PPI rest medicine and I sanitize it by an urea breath test four weeks later and judge it.
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1.The patient of the chronic hepatitis C and cirrhosis of the liver
2.The patient that I understand the contents of this study, and an agreement of the study participation is provided from the person himself by a document
1.The patient with a severe liver damage(Child-pugh classification GradeC)
2.In addition, the patient who judged the chief physician to be inappropriate as an object of this study
100
1st name | |
Middle name | |
Last name | syuhei nishiguchi |
hyogo college of medicine
hepatobiliary and pancreas internal medicine
1-1 mukogawa-cho nishinomiya hyogo
0798456474
tomo0204@yahoo.co.jp
1st name | |
Middle name | |
Last name | tomoyuki takashima |
hyogo college of medicine
hepatobiliary and pancreas internal medicine
1-1 mukogawa-cho nishinomiya hyogo
0798-45-6472
tomo0204@yahoo.co.jp
Hyogo College of Medicine hepatobiliary and pancreas internal medicine
Hyogo College of Medicine
NO
2009 | Year | 10 | Month | 01 | Day |
Unpublished
Open public recruiting
2009 | Year | 09 | Month | 01 | Day |
2009 | Year | 09 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2009 | Year | 09 | Month | 29 | Day |
2015 | Year | 10 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003132